Skip to main content

Table 3 Prevalence of men and women following the dietary reference intake (DRI) for selected nutrients

From: Dietary profile of patients with Stargardt’s disease and Retinitis Pigmentosa: is there a role for a nutritional approach?

 

Stargardt’s disease

Retinitis pigmentosa

 

Males (n = 12)

Females (n = 12)

Males (n = 23)

Females (n = 33)

Carbohydrates (45–60 % TE), n (%)

11 (91.7)

7 (58.3)

13 (56.5)

23 (69.7)

Protein (15–20 % TE), n (%)

7 (58.3)

7 (58.3)

14 (60.9)

22 (66.7)

Fats (<30 % TE), n (%)

2 (16.7)

3 (25)

5 (21.7)

6 (18.7)

SFA (<10 % of total fats), n (%)

8 (66.7)

7 (58.3)

15 (65.2)

19 (57.6)

MUFA (15–20 % of total fats), n (%)

8 (66.7)

5 (41.7)

10 (43.5)

15 (45.5)

PUFA (5–10 % of total fats), n (%)

0 (0)

0 (0)

1 (4.3)

0 (0)

Cholesterol (<200 mg), n (%)

3 (25)

6 (50)

5 (21.7)

8 (24.2)

Dietary fibre (>25 g), n (%)

0 (0)

0 (0)

0 (0)

1 (3)

Vitamin A (600–700 μg RAE), n (%)

1 (8.3)

5 (41.7)

2 (8.7)

2 (6.1)

EPA + DHA (>250 mg), n (%)

10 (83.3)

4 (33.3)

15 (65.2)

24 (72.7)

  1. DRIs for the selected macronutrient or nutrient are reported in brackets
  2. STGD Stargardt’s Disease, PR pigmentosa retinitis, TE total energy, SFA saturated fats, MUFA monounsaturated fats, PUFA polyunstaurated fats, EPA eicosapentaenoic acid, RAE retinal activity equivalent, DHA docosahexaenoic acid